• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Adagio Therapeutics

change direction new plan alter arrows move reprioritize
Biotech

Invivyd evolves yet again to keep pace with COVID-19

Invivyd, launched in the early days of the pandemic as Adagio to find treatments for COVID-19, is hoping the third monoclonal antibody is the charm.
Annalee Armstrong Mar 6, 2023 10:45am
Layoffs

Invivyd faces C-suite departures, commercial layoffs

Oct 14, 2022 10:29am
image of a few paragliders

Catalent shakes up leadership, taps new CEO—Chutes & Ladders

Jul 8, 2022 9:30am
CEO chair executive leadership

Adagio selects permanent CEO after founding leader's resignation

Jul 5, 2022 11:17am
Resist resistance fight against cancer arrows out tumor immunotherapy

Adagio still hopes to build omicron offense for COVID-19 therapy

May 13, 2022 10:31am
venture capital funding

Biotech's top 10 money raisers of 2021

Apr 18, 2022 3:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings